imatinib - 1 a pharma tablet, film coated 400mg
1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - imatinib mesilate - film-coated tablet - imatinib mesilate 400 mg - antineoplastic agents
imatinib
rex medical ltd - imatinib mesilate 478mg equivalent to imatinib 400 mg - capsule - 400 mg - active: imatinib mesilate 478mg equivalent to imatinib 400 mg excipient: colloidal silicon dioxide crospovidone gelatin iron oxide red iron oxide yellow lactose magnesium stearate purified water titanium dioxide - - treatment of adult and paediatric patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (ph+cml). - treatment of adult and paediatic patients with ph+cml in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy. - treatment of adult patients with new diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+all) integrated with chemotherapy. - treatment of adult patients with relapsed or refractory ph+all as monotherapy. - treatment of adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. - treatment of adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel). - treatment of adult patients with unresectable, recurrent and/or metastatic dermatofibrosarcoma protuberans (dfsp).
imatinib boston biopharma 100mg hard capsules
boston biopharma limited malta life sciences park, building 2, level 0, san gwann sgn 3000, malta - imatinib mesilate - hard capsule - imatinib mesilate 100 mg - antineoplastic agents
imatinib boston biopharma 200mg hard capsules
boston biopharma limited malta life sciences park, building 2, level 0, san gwann sgn 3000, malta - imatinib mesilate - hard capsule - imatinib mesilate 200 mg - antineoplastic agents
imatinib rowex 100mg film-coated tablets
rowex ltd newtown bantry, co. cork, , ireland - imatinib mesilate - film-coated tablet - imatinib mesilate 100 mg - antineoplastic agents
imatinib rowex 400mg film-coated tablets
rowex ltd newtown bantry, co. cork, , ireland - imatinib mesilate - film-coated tablet - imatinib mesilate 400 mg - antineoplastic agents
imatinib mylan
viatris limited - imatinib mesilate 478mg equivalent to imatinib base 400 mg - film coated tablet - 400 mg - active: imatinib mesilate 478mg equivalent to imatinib base 400 mg excipient: colloidal silicon dioxide crospovidone hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose povidone purified talc purified water - - treatment of adult and paediatric patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) (for paediatric use see section dosage and administration). - treatment of adult and paediatric patients with ph+ cml in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy (for paediatric use see section dosage and administration).
imatinib ab 100 mg film-coat. tabl.
aurobindo sa-nv - imatinib mesilate 119,47 mg - eq. imatinib 100 mg - film-coated tablet - 100 mg - imatinib mesilate 119.47 mg - imatinib
imatinib ab 400 mg film-coat. tabl.
aurobindo sa-nv - imatinib mesilate 477,88 mg - eq. imatinib 400 mg - film-coated tablet - 400 mg - imatinib mesilate 477.88 mg - imatinib
imatinib eg 100 mg film-coat. tabl.
eg sa-nv - imatinib mesilate 119,47 mg - eq. imatinib 100 mg - film-coated tablet - 100 mg - imatinib mesilate 119.47 mg - imatinib